Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Rhinitis or nasal congestion related ailments symptoms 2) Fitness to participate in the trial 3) Informed consent with a willingness to follow up for clinical and laboratory studies 4) Age above 18 years
Exclusion criteria
Exclusion criteria: 1)People with Co-morbidities (eg. Diabetes, malignancies, hyperthyroidism) 2) On other medicines for treating allergic rhinitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment of allergic rhinitis as measured by the standard Nasal Obstruction Score based on comparison of JaSE versus control at the end of the trial. Timepoint: Baseline, 2 weeks and 4 weeks. Follow up on 15th, 30th day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in CRP, sIgA, CD4, IgE level.Timepoint: 15th day post starting the treatment. | — |
Countries
India
Contacts
BKL Walawalkar Rural Medical College and Hospital